Publication October 29, 2026

New Publication Discusses Goserelin Case: Testicular Metastasis in CRPC

A publication involving goserelin was listed on October 29, 2026. The article, titled "Isolated testicular metastasis as a rare manifestation of castration-resistant prostate cancer," appeared in Urology Case Reports. Goserelin is an approved therapy referenced in the context of this case report. The publication is indexed with PubMed ID 43022848. No findings, outcomes, or efficacy data from the publication are included here beyond its title and journal of record. This entry reflects only the existence and bibliographic details of the new publication as listed. Readers interested in castration-resistant prostate cancer research and related case reports may wish to consult the original source for full details. The item is noted as a case report format, which typically describes individual clinical presentations rather than broader trial results. No additional context, such as study design or patient outcomes, was provided in the event data. For general background on goserelin, including its approved regulatory status and standard use, readers can refer to the compound overview.

See the full goserelin overview

Source: https://pubmed.ncbi.nlm.nih.gov/43022848/